ReviewOncoTargets and therapy2018

Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer.

Ran Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.